Furthermore, Passarella et al. revealed that GIRLRG-modified nanocomplexes increase the accumulation and induce apoptosis in irradiated breast cancers over a 3-week period, further underscoring the potential significance of targeting GRP78 in cancer therapies [50]. This evidence concerns the gene HSPA5 and breast carcinoma.